KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Inventory Average (2021 - 2025)

Historic Inventory Average for Moderna (MRNA) over the last 5 years, with Q3 2025 value amounting to $286.0 million.

  • Moderna's Inventory Average fell 2946.98% to $286.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $286.0 million, marking a year-over-year decrease of 2946.98%. This contributed to the annual value of $159.5 million for FY2024, which is 7228.5% down from last year.
  • Latest data reveals that Moderna reported Inventory Average of $286.0 million as of Q3 2025, which was down 2946.98% from $184.0 million recorded in Q2 2025.
  • Moderna's Inventory Average's 5-year high stood at $2.0 billion during Q3 2022, with a 5-year trough of $122.5 million in Q1 2025.
  • Moreover, its 5-year median value for Inventory Average was $568.5 million (2021), whereas its average is $755.2 million.
  • In the last 5 years, Moderna's Inventory Average soared by 52532.35% in 2022 and then plummeted by 7723.07% in 2023.
  • Moderna's Inventory Average (Quarter) stood at $1.2 billion in 2021, then increased by 25.77% to $1.5 billion in 2022, then crashed by 77.23% to $344.5 million in 2023, then decreased by 23.22% to $264.5 million in 2024, then grew by 8.13% to $286.0 million in 2025.
  • Its Inventory Average was $286.0 million in Q3 2025, compared to $184.0 million in Q2 2025 and $122.5 million in Q1 2025.